Evidence map›Paper›PMID 26800284›Full record

ArticleBiotechnic & histochemistry : official publication of the Biological Stain Commission2016

Salivary and serum procalcitonin and C-reactive protein as biomarkers of periodontitis in United States veterans with osteoarthritis or rheumatoid arthritis.

R S Redman, G S Kerr, J B Payne, T R Mikuls, J Huang, H R Sayles, K L Becker, E S Nylén

Abstract read
In one paragraph

Article in Biotechnic & histochemistry : official publication of the Biological Stain Commission, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Microbiota of Saliva: A Non-invasive Diagnostic Tool.Indian journal of microbiology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

R S Redmana Dental Service and Oral Pathology Research Laboratory , Department of Veterans Affairs Medical Center , Washington , DC.
G S Kerrb Rheumatology Section, Medical Service, Department of Veterans Affairs Medical Center , Washington , DC , and Department of Rheumatology , College of Medicine, Howard University , Washington , DC.
J B Paynec Department of Surgical Specialties , College of Dentistry, University of Nebraska Medical Center , Lincoln, Nebraska and Department of Internal Medicine , College of Medicine, University of Nebraska Medical Center , Omaha, Nebraska.
T R Mikulsd College of Medicine, University of Nebraska Medical Center , Omaha, Nebraska and Veterans Affairs Nebraska-Western Iowa Health Care Center , Omaha, Nebraska.
J Huangb Rheumatology Section, Medical Service, Department of Veterans Affairs Medical Center , Washington , DC , and Department of Rheumatology , College of Medicine, Howard University , Washington , DC.
H R Saylese College of Public Health, University of Nebraska Medical Center , Omaha, Nebraska.
K L Beckerf Endocrinology Section, Medical Service, Department of Veterans Affairs Medical Center , Washington , DC.
E S Nylénf Endocrinology Section, Medical Service, Department of Veterans Affairs Medical Center , Washington , DC.
Howard University · USNebraska Medical Center · USSurgical Specialties (United States) · USUniversity of Nebraska Medical Center · US

Funding

Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1TR000101 · NCATS · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2012 to 2015
$19.3M
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUUL1RR031975 · NCRR · GEORGETOWN UNIVERSITY · PI MELLMAN, THOMAS A, VERBALIS, JOSEPH G · 2010 to 2011
$14.6M
NCATS NIH HHS UL1 TR000101NCATS NIH HHS UL1TR000101NCATS NIH HHS UL1 TR001409NCRR NIH HHS UL1 RR031975NCRR NIH HHS UL1RR031975
6 · The paper itself

Abstract

Serum procalcitonin (ProCT) is elevated in response to bacterial infections, whereas high sensitivity C-reactive protein (hsCRP) is a nonspecific inflammatory marker that is increased by excess adipose tissue. We examined the efficacy of ProCT and hsCRP as biomarkers of periodontitis in the saliva and serum of patients with arthritis, which is characterized by variable levels of systemic inflammation that potentially can confound the interpretation of inflammatory biomarkers. Blood and unstimulated whole saliva were collected from 33 patients with rheumatoid arthritis (RA) and 50 with osteoarthritis (OA). Periodontal status was assessed by full mouth examination and patients were categorized as having no/mild, moderate or severe periodontitis by standard parameters. Salivary and serum ProCT and hsCRP concentrations were compared. BMI, diabetes, anti-inflammatory medications and smoking status were ascertained from the patient records. Differences between OA and RA in proportionate numbers of patients were compared for race, gender, diabetes, adiposity and smoking status. Serum ProCT was significantly higher in arthritis patients with moderate to severe and severe periodontitis compared with no/mild periodontitis patients. There were no significant differences in salivary ProCT or salivary or serum hsCRP in RA patients related to periodontitis category. Most of the OA and RA patients were middle aged or older, 28.9% were diabetic, 78.3% were overweight or obese, and slightly more than half were either current or past smokers. The OA and RA groups differed by race, but not gender; blacks and males were predominant in both groups. The OA and RA groups did not differ in terms of controlled or uncontrolled diabetes, smoking status or BMI. The RA patients had been prescribed more anti-inflammatory medication than the OA patients. Our results demonstrate that circulating ProCT is a more discriminative biomarker for periodontitis than serum hsCRP in patients with underlying arthritis. Any elevation in salivary and serum hsCRP due to periodontitis apparently was overshadowed by differences among these patients in factors that influence CRP, such as the extent of inflammation between RA and OA, the extent of adipose tissue, the use of anti- inflammatory medications and smoking status. Although our study showed no differences in salivary ProCT related to severity of periodontitis, this biomarker also may be useful with further refinement.

Indexed as

AdultAgedAged, 80 and overArthritis, RheumatoidBiomarkersCalcitoninC-Reactive ProteinFemaleHumansMaleMiddle AgedOsteoarthritisPeriodontitisProtein PrecursorsSalivaUnited StatesBiomarkersCalcitoninC-Reactive ProteinProtein PrecursorsC-reactive proteingingivitisosteoarthritisperiodontitisprocalcitoninsaliva

Identifiers

PMID26800284
PMCPMC4802963
OpenAlexW2251035960

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.